Takeda divesting $10B in non-core assets following completed Shire acquisition

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said Jan. 7 that

Read the full 91 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE